(Q53634760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Alessio Stefanucci

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Dario Rusciano

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Nicola Pescosolido

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

20 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

Ophthalmic and Physiological Optics

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

201-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture

28 February 2020

cites work

1 reference

Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues

21 January 2018

1 reference

The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential

21 January 2018

1 reference

A randomized controlled trial with bright light and melatonin for the treatment of delayed sleep phase disorder: effects on subjective and objective sleepiness and cognitive function

21 January 2018

1 reference

Agomelatine, a melatonin agonist with antidepressant properties

21 January 2018

1 reference

The role of melatonin in the cells of the innate immunity: a review

21 January 2018

1 reference

Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues

21 January 2018

1 reference

Melatonin: an underappreciated player in retinal physiology and pathophysiology

21 January 2018

1 reference

Melatonin receptors in the eye: location, second messengers and role in ocular physiology

21 January 2018

1 reference

The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye.

21 January 2018

1 reference

Melatonin in the eye: implications for glaucoma

21 January 2018

1 reference

Identification of the melatonin-binding site MT3 as the quinone reductase 2.

21 January 2018

1 reference

Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes

21 January 2018

1 reference

Agomelatine in depression

21 January 2018

1 reference

Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma

21 January 2018

1 reference

How does lowering of intraocular pressure protect the optic nerve?

21 January 2018

1 reference

New therapeutic targets for intraocular pressure lowering.

21 January 2018

1 reference

Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.

21 January 2018

1 reference

Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia

21 January 2018

1 reference

Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay

21 January 2018

1 reference

Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits

21 January 2018

1 reference

Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting

21 January 2018

1 reference

Role of dopaminergic receptors in glaucomatous disease modulation

21 January 2018

1 reference

Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT.

21 January 2018

1 reference

The effect of melatonin on aqueous humor flow in humans during the day.

21 January 2018

1 reference

Trabecular meshwork in normal and pathological eyes

21 January 2018

1 reference

Antioxidative Protection by Melatonin: Multiplicity of Mechanisms from Radical Detoxification to Radical Avoidance

21 January 2018

1 reference

Melatonin in Alzheimer's disease and other neurodegenerative disorders

21 January 2018

1 reference

The potential of neuroprotection in glaucoma treatment

21 January 2018

1 reference

Protective effects of melatonin in experimental free radical-related ocular diseases.

21 January 2018

1 reference

Physiological concentrations of melatonin inhibit the nitridergic pathway in the Syrian hamster retina.

21 January 2018

1 reference

Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity

21 January 2018

1 reference

Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection

21 January 2018

1 reference

Environmental stimulus perception and control of circadian clocks

21 January 2018

1 reference

Assessment of the retinal nerve fiber layer in clinical trials of glaucoma neuroprotection

21 January 2018

1 reference

Circadian rhythm dysfunction in glaucoma: A hypothesis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/OPO.12189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25600174%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference